Objective To determine the economic impact of medication non-adherence across multiple
disease groups. Design Systematic review. Evidence review A comprehensive literature …

The delivery of psychiatric care is changing with a new emphasis on integrated care,
preventative measures, population health, and the biological basis of disease. Fundamental …

Purpose To examine the association and the mediating effect among medication beliefs,
perception of illness, and medication adherence in ischemic stroke patients. Patients and …

Background Schizophrenia (SZ) and bipolar I disorder (BD-I) are chronic mental health
disorders often treated with antipsychotic medications. This qualitative study sought to better …

Oral atypical antipsychotic (OAAP) medications are the most commonly prescribed treatment
for the management of schizophrenia symptoms. This retrospective study, using Medicaid …

Background Bipolar disorder type I (BD-I) is a chronic condition characterized by mania
episodes followed by syndromic recovery periods, usually permeated by depressive …

It is important to examine the psychotropic prescription practices in schizophrenia, as it can
inform regarding changing treatment choices and related patient profiles. No recent reviews …

Background A recent large database analysis raised concerns of potential acute kidney
injury (AKI) risk associated with antipsychotics. However, whether individual atypical and …

Introduction Technology has permeated every aspect of our existence and the mental health
sector is not exempt from this. Objectives The aim of this study was to test the impact of using …

The course of schizophrenia is characterized by multiple relapses, incomplete remission of
symptoms, enduring cognitive deficits, and social and occupational functional impairments …